Literature DB >> 26656455

Transplantation: The role of RAAS blockade in kidney transplantation.

Robert D Toto1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26656455      PMCID： PMC4760842          DOI： 10.1038/nrneph.2015.201

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

2.  Early use of renin-angiotensin-aldosterone system inhibitors after renal transplantation.

Authors:  Christophe Mariat
Journal:  Nat Clin Pract Nephrol       Date:  2008-04-29

Review 3.  Hypertension, living kidney donors, and transplantation: where are we today?

Authors:  Ana P Rossi; John P Vella
Journal:  Adv Chronic Kidney Dis       Date:  2015-03       Impact factor: 3.620

4.  Kidney graft survival in Europe and the United States: strikingly different long-term outcomes.

Authors:  Adam Gondos; Bernd Döhler; Hermann Brenner; Gerhard Opelz
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

5.  Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET.

Authors:  Thomas Philipp; Franck Martinez; Helmut Geiger; Bruno Moulin; Georges Mourad; Roland Schmieder; Michel Lièvre; Uwe Heemann; Christophe Legendre
Journal:  Nephrol Dial Transplant       Date:  2009-11-03       Impact factor: 5.992

6.  Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.

Authors:  Georg Heinze; Christa Mitterbauer; Heinz Regele; Reinhard Kramar; Wolfgang C Winkelmayer; Gary C Curhan; Rainer Oberbauer
Journal:  J Am Soc Nephrol       Date:  2006-02-15       Impact factor: 10.121

7.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

Authors:  E J Lewis; L G Hunsicker; R P Bain; R D Rohde
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

8.  Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.

Authors:  Greg A Knoll; Dean Fergusson; Michaël Chassé; Paul Hebert; George Wells; Lee Anne Tibbles; Darin Treleaven; David Holland; Christine White; Norman Muirhead; Marcelo Cantarovich; Michel Paquet; Bryce Kiberd; Sita Gourishankar; Jean Shapiro; Ramesh Prasad; Edward Cole; Helen Pilmore; Valerie Cronin; Debora Hogan; Tim Ramsay; John Gill
Journal:  Lancet Diabetes Endocrinol       Date:  2015-10-23       Impact factor: 32.069

9.  Calcineurin-inhibition Results in Upregulation of Local Renin and Subsequent Vascular Endothelial Growth Factor Production in Renal Collecting Ducts.

Authors:  Ágnes Prókai; Rózsa Csohány; Erna Sziksz; Domonkos Pap; Leonóra Balicza-Himer; Szilvia Boros; Balázs Magda; Ádám Vannay; Katalin Kis-Petik; Andrea Fekete; János Peti-Peterdi; Attila J Szabó
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

10.  Angiotensin II blockade in kidney transplant recipients.

Authors:  Hassan N Ibrahim; Scott Jackson; Jeffery Connaire; Arthur Matas; Arthur Ney; Behzad Najafian; Ann West; Nicole Lentsch; Jensina Ericksen; Jenny Bodner; Bertram Kasiske; Michael Mauer
Journal:  J Am Soc Nephrol       Date:  2013-01-10       Impact factor: 10.121
  10 in total
  5 in total

1.  Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment.

Authors:  Claudio Ponticelli; David Cucchiari
Journal:  J Nephrol       Date:  2017-02-17       Impact factor: 3.902

2.  Molecular remodeling of the renin-angiotensin system after kidney transplantation.

Authors:  Marlies Antlanger; Oliver Domenig; Johannes J Kovarik; Christopher C Kaltenecker; Chantal Kopecky; Marko Poglitsch; Marcus D Säemann
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Apr-Jun       Impact factor: 1.636

3.  The Effect of Renin-angiotensin System Inhibitors on Kidney Allograft Survival: A Systematic Review and Meta-analysis.

Authors:  Wisit Cheungpasitporn; Charat Thongprayoon; Michael A Mao; Wonngarm Kittanamongkolchai; Insara J J Sathick; Stephen B Erickson
Journal:  N Am J Med Sci       Date:  2016-07

4.  Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation.

Authors:  Johannes J Kovarik; Christopher C Kaltenecker; Chantal Kopecky; Oliver Domenig; Marlies Antlanger; Johannes Werzowa; Farsad Eskandary; Renate Kain; Marko Poglitsch; Sabine Schmaldienst; Georg A Böhmig; Marcus D Säemann
Journal:  Sci Rep       Date:  2019-07-05       Impact factor: 4.379

Review 5.  Kidney disease in non-kidney solid organ transplantation.

Authors:  Kurtis J Swanson
Journal:  World J Transplant       Date:  2022-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.